Back to All Events

2026 Best of ASCO® Las Vegas


  • Westin Lake Las Vegas 101 Montelago Blvd Henderson/Las Vegas, NV (map)

In-Person Access Only | 7.75 CE/CME Credits & MOC Points

Please read:All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

Total Health's 2026 Best of ASCO® Las Vegas Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.

 

Program Chairs:
Oscar Goodman, MD, PhD (Nevada Oncology Specialists)
Heloisa Soares, MD, PhD (Huntsman Cancer Institute)

Conference Agenda
Saturday, July 25, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome
Oscar Goodman, MD, PhD | Nevada Oncology Specialists

8:40 AM
Colorectal Cancer

Khaled Abouelezz, MD, M.Ed | City of Hope

9:10 AM
Non-Colorectal Cancer

Saurin Chokshi, MD | University of Tennessee Health Science Center

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Sumitomo/Pfizer Orgovyx


10:40 AM
Prostate Cancer

Oscar Goodman, MD, PhD | Nevada Oncology Specialists

11:10 AM
Non-Prostate Cancer

Kyaw Zin Thein, MD | Comprehensive Cancer Centers of Nevada

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch - Incyte - Monjuvi + Rituximab & Lenalidomide: The First and Only CD19- and CD20-targeted Immunotherapy Combination for 2L+ Follicular Lymphoma Patients
Abhijeet Kumar, MD | Banner University Medical Group, University of Arizona

12:40 PM
Housekeeping and Survey

12:50 PM
Leukemia

Eunice Wang, MD | Roswell Park Comprehensive Cancer Center

1:20 PM
Lymphoma

Muhammad Bilal Abid, MD | Texas Tech University Health Sciences Center

1:50 PM
Multiple Myeloma
Danai Dima, MD | Fred Hutchinson Cancer Center

2:20 PM
Melanoma

Wolfram Samlowski, MD | Nevada Oncology Specialists‍ ‍
‍ ‍‍ ‍

2:50 PM
Adjourn

Sunday, July 26, 2026

7:30 AM
Coffee and Exhibits

8:00 AM
Program Chair Welcome

Heloisa Soares, MD, PhD | Huntsman Cancer Institute

8:10 AM
Small Cell Lung Cancer
Robert Hsu, MD | University of Southern California‍ ‍

8:40 AM
Non-Small Cell Lung Cancer
Matthew Gumbleton, MD, PhD | Huntsman Cancer Institute


9:10 AM
The Emerging Role of PD-1 × VEGF Bispecific Antibodies in NSCLC
Matthew Gumbleton, MD, PhD | Huntsman Cancer Institute


9:30 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Abbvie Elahere - Mirvetuximab Soravtansine: A FRα Targeted ADC for Platinum Resistant Ovarian Cancer

Nashel Patel | AbbVie

10:40 AM
Head and Neck Cancer
Ranee Mehra, MD, PhD | University of Maryland Greenebaum Comprehensive Cancer Center

11:10 AM
Sarcomas and Rare Cancers
Lee Cranmer, MD, PhD | City of Hope

11:40 PM
Neuroendocrine Tumors

Heloisa Soares, MD, PhD | Huntsman Cancer Institute

12:00 PM
Lunch and Exhibits

12:15 PM
Non-CME Lunch - Pfizer - Learn About a Treatment Option for Patients With HR+/HER2+ mBC

David Page, MD | Providence Cancer Institute

1:00 PM
Ovarian Cancer
Dana Chase, MD | UCLA


1:30 PM
Early-Stage Breast Cancer
Eleonora Teplinsky, MD | Valley Health

2:00 PM
Metastatic Breast Cancer
Lee Schwartzberg, MD | Renown Health-Pennington Cancer Institute

2:30 PM
Adjourn

Agenda Subject To Change. All times are PST.

 
 
Previous
Previous
July 25

2026 Best of ASCO® Seattle

Next
Next
July 25

2026 Best of ASCO® Indianapolis